| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0042 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |